ThailandHealthcare and life sciences2026 – ongoingBangkok Dusit Medical Services (BDMS)
AI pharmacogenomics for drug-allergy risk
BDMS said AI helped prevent adverse drug reactions in more than 3,500 cases
Problem
Drug allergies exposed patients to adverse reactions.
Approach
BDMS implemented AI pharmacogenomics analysis. It identified genetic risks associated with drug allergies.
Results
more than 3,500cases in which AI reportedly helped prevent adverse drug reactions
Takeaway
BDMS reported prevented reactions without explaining the comparison method.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Partner co-development
- Goal
- Quality and risk
- Evidence
- Company's own claim
Sources
Source summaries
[1]BDMS9 Apr 2026
BDMS described AI drug-allergy analysis. It reported prevented adverse reactions.
Full details are in the original sources.
Added 1 Nov 2026 · Updated 1 Nov 2026
